Meeting
2014 ASCO Annual Meeting
Prognostic potential of MDM2 309T>G polymorphism in stage I lung adenocarcinoma.
Authors
Kimihiro Shimizu
Division of Thoracic and Visceral Organ Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan
Kimihiro Shimizu , Yasuaki Enokida , Jun Atsumi , Seiichi Kakegawa , Yoshiaki Takase , Seshiru Nakazawa , Toshiteru Nagashima , Yoichi Ohtaki , Kazumi Tanaka , Kyoichi Kaira , Izumi Takeyoshi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Genomic and Epigenomic Biomarkers
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 11055)
DOI
10.1200/jco.2014.32.15_suppl.11055
Abstract #
11055
Poster Bd #
337
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in “pan-negative” lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history.
First Author: Alexander E. Drilon
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Genomic characterization of unresectable/recurrent early-onset gastric cancer by comprehensive genomic profiling tests.
First Author: Kunihito Matsuguma
Poster
2018 ASCO Annual Meeting
The comparison of tumor mutational burden (TMB) in patients of early and late stage lung adenocarcinoma in China.
First Author: Kai Zhang
Poster
2023 ASCO Annual Meeting
Development and validation of a prediction model for the recurrence of stage 1 EGFR mutation positive NSCLC in patients using machine learning with WES-based gene sets.
First Author: Akiko Tateishi